2014
DOI: 10.7754/clin.lab.2013.130216
|View full text |Cite
|
Sign up to set email alerts
|

Genomic Diversity and Virulence Genes among Clinical Isolates of Pseudomonas aeruginosa

Abstract: Background: Typing of nosocomial pathogens is necessary to determine the source of an outbreak. The aim was to determine the genomic variability among Pseudomonas aeruginosa (P. aeruginosa) by random amplification of polymorphic DNA (RAPD) and enterobacterial repetitive intergenic consensus (ERIC) methods. Methods: Fifty P. aeruginosa isolates were obtained from the hospitals. The source of these isolates were burn wound and urinary tract infections. After detection of P. aeruginosa by biochemical methods, chr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 18 publications
1
3
0
1
Order By: Relevance
“…Few other reports on ERIC-PCR based study on genomic variability of P. aeruginosa also support our findings although the isolates were from several other clinical sources in addition to burn patient [33][34][35].…”
Section: Discussionsupporting
confidence: 92%
“…Few other reports on ERIC-PCR based study on genomic variability of P. aeruginosa also support our findings although the isolates were from several other clinical sources in addition to burn patient [33][34][35].…”
Section: Discussionsupporting
confidence: 92%
“…DNA was extracted from the bacterial cells grown in TSB as described earlier by other authors [ 20 , 21 ]. Briefly, bacterial cells were centrifuged at 15,000 × g for five minutes and washed in 1 mL of MNacl.…”
Section: Methodsmentioning
confidence: 99%
“…Pseudomonas aeruginosa , a major opportunistic pathogen causing a diverse range of human infections, is the most frequently isolated pathogen from sputum of patients with cystic fibrosis (CF) lung disease (1). Among multiple pathogenic elements involved in infection process (2), type III secretion system (T3SS) effectors have been well studied and recognized as key for establishing infection (3). Currently, four type III-secreted effector proteins, ExoS, ExoT, ExoU, ExoY, have been recognized in P. aeruginosa (4, 5, 6).…”
Section: Introductionmentioning
confidence: 99%